anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

211,801-211,860 of 319,975

filter-aware
12
The slide uses stacked bar charts to break down AUM by asset type (Yield, Hybrid, Equity) and Perpetual Capital by source (Athene, Athora, Other).Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
13
The chart displays two distinct time series: annual (2018-LTM 2Q'23) and quarterly (3Q'22-2Q'23).Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
14
Includes footnotes regarding LDTI accounting standard adoption and specific adjustments for interest/financing costs and other notable items.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
15
The slide uses a stacked bar chart for inflows and a bar chart for earnings, with a callout for a 16x growth factor.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
16
Includes both actual and normalized net spread bridge charts.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
17
Includes a donut chart for portfolio composition and a bar chart for historical performance.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
18
The slide provides a quarterly and year-to-date comparison of financial metrics for the Principal Investing segment.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
19
The slide uses three donut charts to visualize the composition of AUM and Dry Powder.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
20
Includes a table of gross returns and a waterfall bridge chart for performance fees.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
21
Includes footnotes detailing specific financial exclusions and definitions.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · TeamLoop · Cost Of Inaction1 hit
22
Apollo Global Management | Results Presentation Deck | 41 slidesApollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
23
The slide contains four distinct financial tables representing AUM movements across different timeframes and categories.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
24
Includes footnotes regarding normalization of alternative investment income and other notable items.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
25
Contains multiple tables detailing invested assets, flow channels, and outflow types/rates.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
26
Includes footnotes detailing acquisition shares, repurchase methodology, and authorization limits.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
27
Apollo Global Management | Results Presentation Deck | 41 slidesApollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
28
Includes footnotes explaining fund exclusions and IRR calculation methodology for newer funds.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
29
Data presented in millions of dollars.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
30
Financial statement data presented in millions of dollars.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
31
Includes footnotes detailing specific adjustments like equity-based profit sharing and transaction-related charges.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
32
Includes footnotes explaining specific adjustments like equity-based profit sharing and merger-related costs.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
33
Contains multiple sub-tables for different financial metrics.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
34
The table shows adjustments for investment gains, insurance liabilities, integration expenses, and stock compensation.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
35
The slide contains two distinct financial tables.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
36
Standard financial disclosure slide defining key performance indicators.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
37
Standard financial disclosure slide defining key performance metrics.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
38
Apollo Global Management | Results Presentation Deck | 41 slidesApollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
39
This is a standard disclosure slide for financial terminology.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
40
This is a standard appendix slide for financial disclosures.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
41
Apollo Global Management | Results Presentation Deck | 41 slidesApollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
01
Slide 1
Arbutus Biopharma | Investor Presentation Deck | 28 slidesArbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
02
Arbutus Biopharma | Investor Presentation Deck | 28 slidesArbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
03
Arbutus Biopharma | Investor Presentation Deck | 28 slidesArbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
04
The slide uses a structured grid layout to present key value drivers.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
05
The slide uses a Gantt-style visualization to show drug development stages.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
06
The slide uses a four-column layout to structure the disease overview.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
07
Uses a geographic map and a nested circle diagram to illustrate the treatment gap.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
08
The slide uses a process-oriented flow diagram to explain the mechanism of action for a combination therapy.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
09
The slide highlights the mechanism of action targeting multiple HBV transcripts.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
10
The slide outlines study design for Part 1, 2, and 3 of a clinical trial for chronic hepatitis B (cHBV).Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
11
Data presented at Global Hepatitis Summit 2023. Includes specific cohort N values and standard error (SE) in parentheses.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
12
The slide displays six longitudinal line charts representing different patient cohorts, with specific callouts for clinical outcomes.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
13
Clinical trial data showing individual patient responses over time.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
14
Data presented at EASL 2022. Shows correlation between T-cell activation and HBsAg reduction.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
15
The slide uses a bulleted list to present key safety outcomes, including lack of serious adverse events and specific laboratory findings.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
16
Arbutus Biopharma | Investor Presentation Deck | 28 slidesArbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
17
The slide outlines a clinical trial timeline and key efficacy metrics for a chronic hepatitis B (cHBV) treatment.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
18
The slide outlines two parallel study arms with randomization at week 24.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
19
The slide details a specific licensing deal, including financial terms and partner background.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
20
The slide uses a three-column layout to highlight key value propositions.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
21
Includes a line chart for efficacy over time and two bar charts for pharmacokinetic concentrations in plasma vs liver.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
22
Includes IC50 value and IFN-y fold increase data.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
23
The slide uses a three-column layout to explain the scientific basis and product profile.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
24
Arbutus Biopharma | Investor Presentation Deck | 28 slidesArbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
25
Includes a schematic of the SARS-CoV-2 genome and protein structure, alongside specific drug development strategies.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
26
The slide uses a three-pillar framework to summarize the drug's value proposition.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
27
Includes financial metrics (cash balance, runway, burn) as context for the milestones.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
28
Arbutus Biopharma | Investor Presentation Deck | 28 slidesArbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
01
Slide 1
argenx SE | Investor Presentation Deck | 26 slidesargenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Setup1 hit
02
argenx SE | Investor Presentation Deck | 26 slidesargenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Setup1 hit